Skip to main content

Table 2 Distribution of the annual HCRU in TDT treatment per patient per year (2019)

From: Healthcare resource utilization and direct costs of transfusion-dependent thalassemia patients in Dubai, United Arab Emirates: a retrospective cost-of-illness study

Healthcare resource utilization

Median

Average/ patient

Min

Max

Laboratory investigations

113

120

55

376

Radiology and other diagnostic investigations

3

4.0

0

23

Blood transfusion

41

41

7

82

Physician consultation

6

10

0

93

Surgical and other therapeutic procedures

0

1

0

35

Other medications

1104

717

20

5,632

ICT (total)

1,023

1,220

5,846

311,096

 DFX

1,020

1,032

91

3,523

 DFP

2,296

2,599

476

5,832

 DFO

398

782

0

3,822

 Combined therapy

2,143

2,443

373

5,846

  1. ICT iron chelation therapy, DFX deferasirox, DFP deferiprone, DFO deferoxamine